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Summary
Rabies has one of the highest case-fatality ratios of any infectious disease. This report provides recommendations for public health 
officials, veterinarians, animal control officials, and other parties engaged in rabies prevention and control activities and should 
serve as the basis for standardizing procedures among jurisdictions. The recommendations regarding domestic animal vaccination, 
management of animals exposed to rabies, and management of animals that bite humans are the core elements of animal rabies 
control and human rabies prevention. These updated 2011 guidelines include the national case definition for animal rabies and 
clarify the role of the CDC rabies laboratory in providing confirmatory testing of suspect animals. The table of rabies vaccines 
licensed and marketed in the United States has been updated, and additional references have been included to provide scientific 
support for information in this report. 
Introduction
Rabies is a fatal viral zoonosis and a serious public health 
problem (1). All mammals (referred to as animals in this report) 
are believed to be susceptible to the disease. Rabies is an acute, 
progressive encephalitis caused by a lyssavirus. Worldwide, 
rabies virus is the most important lyssavirus. In the United 
States, multiple rabies virus variants are maintained in wild 
mammalian reservoir populations such as raccoons, skunks, 
foxes, and bats.  Although the United States has been declared 
free of canine rabies virus variant transmission, reintroduction 
of this variant is always a risk (2–6). 
Rabies virus usually is transmitted from animal to animal 
through bites. The incubation period is highly variable. In 
domestic animals, the incubation period is generally 3–12 
weeks but can range from several days to months, rarely 
exceeding 6 months (7). Rabies is communicable during the 
period of salivary shedding of rabies virus. Experimental and 
historic evidence indicates that dogs, cats, and ferrets shed virus 
a few days before clinical onset and during illness. Clinical 
signs of rabies and include inappetance, dysphagia, cranial 
nerve deficits, abnormal behavior, ataxia, paralysis, altered 
vocalization, and seizures. Progression to death is rapid. There 
are currently no known effective rabies antiviral drugs.
The recommendations in this compendium serve as a basis 
for animal rabies prevention and control programs throughout 
the United States and facilitate standardization of procedures 
among jurisdictions, thereby contributing to an effective 
national rabies control program.* The most current version 
replaces all previous versions. These recommendations do 
not supersede state and local laws or requirements. Principles 
of rabies prevention and control are detailed in Part I; 
recommendations for parenteral vaccination procedures are 
presented in Part II; and all animal rabies vaccines licensed 
by the U.S. Department of Agriculture and marketed in the 
United States are listed and described in Part III.
Methods
NASPHV periodically updates the recommendations to 
prevent and control animal rabies. The revision includes 
reviewing recent literature, updating licensed vaccine product 
information as provided by the manufacturers, and soliciting 
input from NASPHV members and stakeholder groups. 
During July 15–16, 2010, NASPHV members and external 
expert consultants met in Atlanta, Georgia. A committee 
consensus was required to add or modify existing language or 
recommendations. After the meeting, the updated draft was 
circulated via e-mail for final review by all voting committee 
members. 
The 2011 guidelines include several updates. First, the 
national case definition for animal rabies was added to clarify 
how rabies cases are defined for public health surveillance 
purposes. Second, the diagnostics section was expanded to 
1) clarify that the CDC rabies laboratory is available for 
confirmatory testing and on an emergency basis to expedite 
exposure management decisions, 2) include information on 
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testing methodology appropriate for field testing of surveillance 
specimens, and 3) clarify that no reliable antemortem rabies 
tests are available for use in animals. Third, the research section 
was expanded to include additional topics that warrant further 
study. Finally, the table of rabies vaccines licensed and marketed 
in the United States was updated, and additional references 
were included to provide scientific support for information 
provided in the recommendations.
Part I. Rabies Prevention and Control
A. Principles of Rabies Prevention and Control
1. Case Definition. An animal is determined to be 
rabid after diagnosis by a qualified laboratory as 
specified in Part I.A.9. The national case definition 
for animal rabies requires laboratory confirmation by 
either
•	 a	 positive	 direct	 fluorescent	 antibody	 (DFA)	 test	
(preferably performed on central nervous system 
tissue); or
•	 isolation	 of	 rabies	 virus	 (in	 cell	 culture	 or	 in	 a	
laboratory animal) (8).
2. Rabies Virus Exposure. Rabies virus is transmitted 
when the virus is introduced into bite wounds, into 
open cuts in skin, or onto mucous membranes from 
saliva or other potentially infectious material such 
as neural tissue (9). Questions regarding possible 
exposures should be directed promptly to state or 
local public health authorities.
3. Public Health Education. Essential components 
of rabies prevention and control include ongoing 
public education, responsible pet ownership, routine 
veterinary care and vaccination, and professional 
continuing education. The majority of animal and 
human exposures to rabies virus can be prevented by 
raising awareness concerning rabies virus transmission 
routes, avoiding contact with wildlife, and following 
appropriate veterinary care. Prompt recognition of 
possible exposure and prompt reporting to medical 
professionals and local public health authorities is 
critical. 
4. Human Rabies Prevention. Rabies in humans 
can be prevented either by eliminating exposures 
to rabid animals or by providing persons who 
have been exposed with prompt local treatment 
of wounds combined with the appropriate 
administration of human rabies immune globulin 
and vaccine. Exposure assessment should occur 
before rabies postexposure prophylaxis (PEP) is 
initiated and should include discussions between 
medical providers and public health officials.  
The rationale for recommending preexposure 
prophylaxis and details of both preexposure and 
postexposureprophylaxis administration are available 
in the current recommendations of the Advisory 
Committee on Immunization Practices (ACIP) 
(9,10). These recommendations, in addition to 
information concerning the current local and regional 
epidemiology of animal rabies and the availability of 
human rabies biologics, are available from state health 
departments. 
5. Domestic Animal Vaccination. Multiple vaccines are 
licensed for use in domestic animal species. Vaccines 
available include inactivated or modified live-virus 
vectored products, products for intramuscular 
and subcutaneous administration, products with 
durations of immunity from 1 to 4 years, and 
products with varying minimum age of vaccination. 
The recommended vaccination procedures and 
the licensed animal vaccines are specified in Parts 
II and III of this compendium, respectively. Local 
governments should initiate and maintain effective 
programs to ensure vaccination of all dogs, cats, and 
ferrets and to remove stray and unwanted animals. 
Such procedures in the United States have reduced 
laboratory-confirmed cases of rabies in dogs from 
6,949 in 1947 to 93 in 2009 and are responsible for 
the elimination of the canine rabies virus variant (2). 
Because more rabies cases involving cats are reported 
annually (274 in 2009) than dogs, vaccination of cats 
should be required (2). Animal shelters and animal 
control authorities should establish policies to ensure 
that adopted animals are vaccinated against rabies.
6. Rabies in Vaccinated Animals. Rabies is rare in 
vaccinated animals (11–13). If suspected, the case 
should be reported to public health officials, the 
vaccine manufacturer, and the USDA Animal 
and Plant Health Inspection Service, Center for 
Veterinary Biologics (website: http://www.aphis.usda.
gov/animal_health/vet_biologics/vb_adverse_event.
shtml; telephone: 800-752-6255). The laboratory 
diagnosis should be confirmed and the virus variant 
characterized by the CDC rabies reference laboratory. 
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A thorough epidemiologic investigation should be 
conducted, including documentation of the animal’s 
vaccination history and a description of potential 
rabies exposures.
7. Rabies in Wildlife. Controlling rabies in wildlife 
reservoirs is difficult (14). Vaccination of free-
ranging wildlife or selective population reduction is 
useful in some situations (15); however, the success 
of these procedures depends on the circumstances 
surrounding each rabies outbreak (see Part I. 
C.). Because of the risk for rabies in wild animals 
(especially raccoons, skunks, coyotes, foxes, and bats), 
the American Veterinary Medical Association, the 
American Public Health Association, the Council of 
State and Territorial Epidemiologists, the National 
Animal Control Association, and the National 
Association of State Public Health Veterinarians 
(NASPHV) strongly recommend the enactment 
and enforcement of state laws prohibiting the 
importation, distribution, translocation, and private 
ownership of these animals.
8. Rabies Surveillance. Enhanced laboratory-based 
rabies surveillance and variant typing are essential 
components of rabies prevention and control 
programs. Accurate and timely information and 
reporting is necessary to guide human PEP decisions, 
determine the management of potentially exposed 
animals, aid in discovery of emerging pathogens, 
describe the epidemiology of the disease, and 
assess the need for and effectiveness of vaccination 
programs for domestic animals and wildlife. Every 
animal submitted for rabies testing should be 
reported to CDC to evaluate surveillance trends. 
Electronic laboratory reporting and notification 
of animal rabies surveillance data should be 
implemented (16). Optimal information on animals 
submitted for rabies testing should include species, 
point location, vaccination history, rabies virus 
variant (if rabid), and human or domestic animal 
exposures. A case of rabies in an animal with a history 
of importation into the United States within 60 days 
is immediately notifiable by state health departments 
to CDC; reporting of indigenous cases should follow 
standard notification protocols (17). Integration with 
standard public health reporting and notification 
systems should facilitate the transmission of the data 
discussed in this paragraph.  
9. Rabies Diagnosis
a) DFA. The DFA test is the gold standard for 
rabies diagnosis. The test should be performed 
in accordance with the established national 
standardized protocol (available at http://www.
cdc.gov/rabies/pdf/RabiesDFASPv2.pdf ) by a 
qualified laboratory that has been designated 
by the local or state health department (18,19). 
Animals submitted for rabies testing should be 
euthanized (20,21) in a way that maintains the 
integrity of the brain and allows the laboratory to 
recognize the anatomical parts. Except for very 
small animals, such as bats, only the head or brain 
(including the brain stem) should be submitted 
to the laboratory. To facilitate prompt laboratory 
testing, submitted specimens should be stored 
and shipped under refrigeration (rather than 
frozen) without delay. Thawing frozen specimens 
will delay testing. Chemical fixation of tissues 
should be avoided because it can cause substantial 
testing delays and might preclude reliable testing. 
Questions about testing fixed tissues should be 
directed to the local rabies laboratory or public 
health department.
b) Emergency Rabies Testing. Emergency rabies 
testing should be available to expedite exposure 
management decisions (18). When state health 
departments need confirmatory testing (e.g., 
for inconclusive results, unusual species, or 
mass exposures), the CDC rabies laboratory can 
provide results within 24 hours of submission 
(22).  
c) Direct Rapid Immunohistochemical Test 
(DRIT). DRITs are being used by trained field 
personnel in surveillance programs for specimens 
not involved in human or domestic animal 
exposures (23–26). All positive DRIT results need 
to be confirmed by DFA testing at a qualified 
laboratory.
d) Unlicensed Test Kits. No USDA-licensed rapid 
test kits are commercially available for rabies 
diagnosis. Unlicensed tests should not be used 
for several reasons: the sensitivity and specificity 
are not known; the tests have not been validated 
against current standard methods; the excretion of 
virus in the saliva is intermittent and the amount 
varies over time; any test result would need to be 
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confirmed by more reliable methods such as DFA 
testing on brain tissue; and the interpretation of 
results might place exposed animals and persons 
at risk.
10. Rabies Serology. Certain jurisdictions require 
evidence of vaccination and rabies virus antibodies 
for animal importation. Rabies virus antibody 
titers are indicative of a response to vaccine or 
infection. Titers do not directly correlate with 
protection because other immunologic factors also 
play a role in preventing rabies, and the ability to 
measure and interpret those other factors is not 
well-developed. Therefore, evidence of circulating 
rabies virus antibodies in animals should not be used 
as a substitute for current vaccination in managing 
rabies exposures or determining the need for booster 
vaccinations (27–30).
11. Rabies Research. Information derived from well-
designed studies is essential for the development of 
science-based recommendations. Data are needed 
in several areas, including viral shedding periods 
for domestic livestock and lagomorphs, potential 
shedding of virus in milk, earliest age at which rabies 
vaccination is effective and the protective effects of 
maternal antibodies, duration of immunity, PEP 
protocols for domestic animals, models for treatment 
of clinical rabies, extra label vaccine use in domestic 
animals and wildlife rabies reservoirs, host-pathogen 
adaptations and dynamics, and the ecology of 
wildlife rabies reservoir species, especially in relation 
to the use of oral rabies vaccines.
B. Prevention and Control Methods in Domestic and 
Confined Animals
1. Preexposure Vaccination and Management. 
Parenteral animal rabies vaccines should be 
administered only by or under the direct supervision 
of a licensed veterinarian on the premises. Rabies 
vaccinations may also be administered under the 
supervision of a licensed veterinarian to animals 
being held in animal control shelters before release. 
The veterinarian who signs the rabies vaccination 
certificate must ensure that the person administering 
vaccine is identified on the certificate and is 
appropriately trained in vaccine storage, handling, 
administration, and in the management of adverse 
events. This practice ensures that a qualified and 
responsible person is held accountable for properly 
vaccinating the animal. Within 28 days after 
initial vaccination, a peak rabies virus antibody 
titer is reached, and the animal can be considered 
immunized (29,31–33). An animal is currently 
vaccinated and is considered immunized if the 
initial vaccination was administered at least 28 
days previously or booster vaccinations have been 
administered in accordance with this compendium.
 Regardless of the age of the animal at initial 
vaccination, a booster vaccination should be 
administered 1 year later (see Parts II and III 
for vaccines and procedures). No laboratory or 
epidemiologic data exist to support the annual or 
biennial administration of 3- or 4-year vaccines after 
the initial series. Because a rapid anamnestic response 
is expected, an animal is considered currently 
vaccinated immediately after a booster vaccination 
(34).
a) Dogs, Cats, and Ferrets. All dogs, cats, and 
ferrets should be vaccinated against rabies and 
revaccinated in accordance with Part III of this 
compendium. If a previously vaccinated animal 
is overdue for a booster, the animal should be 
revaccinated. Immediately after the booster, 
the animal is considered currently vaccinated 
and should be placed on a booster schedule, 
depending on the labeled duration of the vaccine 
used.
b) Livestock. All horses should be vaccinated against 
rabies (35). Livestock, including species for which 
licensed vaccines are not available, that have 
frequent contact with humans (e.g., in petting 
zoos, fairs, and other public exhibitions) should be 
vaccinated against rabies (36,37). Consideration 
also should be given to vaccinating particularly 
valuable livestock. 
c) Captive Wild Animals and Hybrids 
(1) Wild animals or hybrids (the offspring of wild 
animals crossbred to domestic animals) should 
not be kept as pets (38–40). No parenteral 
rabies vaccines are licensed for use in wild 
animals or hybrids (41). 
(2) Animals that live in exhibits and in zoological 
parks and are not completely excluded 
from all contact with rabies vectors can 
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become infected. Moreover, wild animals 
might be incubating rabies when initially 
captured.  Therefore, wild-caught animals 
susceptible to rabies should be quarantined 
for a minimum of 6 months. Employees who 
work with animals at such facilities should 
receive preexposure rabies vaccine. The 
use of preexposure or postexposure rabies 
vaccinations for handlers who work with 
animals at such facilities might reduce the 
need for euthanasia of captive animals that 
expose handlers. Carnivores and bats should 
be housed in a manner that precludes direct 
contact with the public (36,37).
2. Stray Animals. Stray dogs, cats, and ferrets should 
be removed from the community. Local health 
departments and animal control officials can enforce 
the removal of strays more effectively if owned 
animals are required to have identification and are 
confined or kept on leash. Stray animals should be 
impounded for at least 3 business days to determine 
whether human exposure has occurred and to give 
owners sufficient time to reclaim animals.
3. Importation and Interstate Movement of Animals
a) International. CDC regulates the importation 
of dogs and cats into the United States (5). 
Importers of dogs must comply with rabies 
vaccination requirements (42 CFR, Part 71.51[c] 
[http://www.cdc.gov/animalimportation/dogs.
html]) and complete CDC form 75.37 (http://
www.cdc.gov/animalimportation/pdf/dog-import.
pdf ). These regulations require dogs imported 
from rabies-endemic countries to be vaccinated 
for rabies and confined for varying periods 
depending on age and prior vaccination status.  
The appropriate health official of the state of 
destination should be notified within 72 hours 
of the arrival of any imported dog required to be 
placed in confinement under these regulations. 
Failure of the owner to comply with these 
confinement requirements should be reported 
promptly to the CDC Division of Global 
Migration and Quarantine (telephone: 404-639-
4528 or 404-639-4537). For emergencies or 
after-hours calls, contact the CDC Emergency 
Operations Center (telephone: 770-488-7100).
 Federal regulations alone will not prevent the 
introduction of rabid animals into the United 
States (3,4,42,43). All imported dogs and cats 
are subject to state and local laws governing 
rabies and should be currently vaccinated against 
rabies in accordance with this compendium. 
Failure of an owner to comply with state or local 
requirements should be referred to the appropriate 
state or local official.
b) Areas with Dog-to-Dog Rabies Transmission. 
Canine rabies virus variants have been eliminated 
in the United States (2,6). Rabid dogs have been 
introduced into the continental United States 
from areas with dog-to-dog rabies transmission 
(3,4,42,43). The movement of dogs for the 
purposes of adoption or sale from areas with 
dog-to-dog rabies transmission increases the risk 
for introducing canine-transmitted rabies to areas 
where the disease does not exist and should be 
prohibited.
c) Interstate. Before interstate (including 
commonwealths and territories) movement, 
dogs, cats, ferrets, and horses should be currently 
vaccinated against rabies in accordance with the 
recommendations in this compendium (see Part 
I.B.1.). Animals in transit should be accompanied 
by a currently valid NASPHV Form 51 (Rabies 
Vaccination Certificate) (http://www.nasphv.
org/Documents/RabiesVacCert.pdf ). When 
an interstate health certificate or certificate of 
veterinary inspection is required, the inspection 
should contain the same rabies vaccination 
information as Form 51.
4. Adjunct Procedures. Methods or procedures that 
enhance rabies control include the following (http://
www.rabiesblueprint.com/spip.php?article119):
a) Identification. Dogs, cats, and ferrets should 
be identified (e.g., metal or plastic tags or 
microchips) to allow for verification of rabies 
vaccination status.
b) Licensure. Registration or licensure of all dogs, 
cats, and ferrets is an integral component of an 
effective rabies control program. A fee frequently 
is charged for such licensure, and revenues 
collected are used to maintain rabies or animal 
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control activities. Evidence of current vaccination 
should be an essential prerequisite to licensure.
c) Canvassing. House-to-house canvassing by 
animal control officials facilitates enforcement of 
vaccination and licensure requirements.
d) Citations. Citations are legal summonses issued 
to owners for violations, including the failure to 
vaccinate or license their animals. The authority 
for officers to issue citations should be an integral 
part of each animal control program.
e) Animal Control. All local jurisdictions should 
incorporate stray animal control, leash laws, 
animal-bite prevention, and training of personnel 
in their programs.
f ) Public Education. All local jurisdictions should 
incorporate education covering responsible pet 
ownership, bite prevention, and appropriate 
veterinary care in their programs.
5. Postexposure Management. This section refers to 
any animal exposed (see Part I.A.2.) to a confirmed or 
suspected rabid animal. Wild mammalian carnivores 
or bats that are not available or suitable for testing 
should be considered rabid.
a) Dogs, Cats, and Ferrets. Any illness in an animal 
that has been exposed to rabies should be reported 
immediately to the local health department. If 
signs suggestive of rabies develop (e.g., paralysis or 
seizures), the animal should be euthanized and the 
head shipped for testing as described in Part I.A.9.
(1) Dogs, cats, and ferrets that have never been 
vaccinated and are exposed to a rabid animal 
should be euthanized immediately. If the 
owner is unwilling to euthanize, the animal 
should be placed in strict isolation for 6 
months. Isolation in this context refers to 
confinement in an enclosure that precludes 
direct contact with people and other animals. 
Rabies vaccine should be administered after 
entry into isolation or up to 28 days before 
release to comply with preexposure vaccination 
recommendations (see Part I.B.1.a.). No 
USDA-licensed biologics for postexposure 
prophylaxis of previously unvaccinated 
domestic animals exist, and evidence indicates 
that the use of vaccine alone does not reliably 
prevent the disease in these animals (44). 
(2) Animals overdue for a booster vaccination 
should be evaluated on a case-by-case basis 
based on severity of exposure, time elapsed 
since last vaccination, number of previous 
vaccinations, current health status, and local 
rabies epidemiologic factors to determine need 
for euthanasia or immediate revaccination and 
observation with isolation. 
(3) Dogs, cats, and ferrets that are currently 
vaccinated should be revaccinated 
immediately, kept under the owner’s control, 
and observed for 45 days. The rationale 
for an observation period is based in part 
on the potential for overwhelming viral 
challenge, incomplete vaccine efficacy, 
improper vaccine administration, variable host 
immunocompetence, and immune-mediated 
fatality (i.e., early death phenomenon) 
(12,45–47).
b) Livestock. All species of livestock are susceptible 
to rabies; cattle and horses are the most frequently 
reported infected species (2). Any illness in an 
animal exposed to rabies should be reported 
immediately to the local health and agriculture 
officials. If signs suggestive of rabies develop, 
the animal should be euthanized and the head 
shipped for testing as described in Part I.A.9. 
(1) Unvaccinated livestock should be euthanized 
immediately. For animals that are not 
euthanized, on a case-by-case basis, they 
should be observed and confined for 6 
months.
(2) Livestock exposed to a rabid animal and 
currently vaccinated with a vaccine approved 
by USDA for that species should be 
revaccinated immediately and observed for 45 
days. 
(3) Multiple rabid animals in a herd or herbivore-
to-herbivore transmission are uncommon (48); 
therefore, restricting the rest of the herd if a 
single animal has been exposed to or infected 
by rabies is usually not necessary.
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(4) Handling and consumption of tissues from 
animals exposed to rabies might carry a risk 
for rabies virus transmission. Risk factors 
depend in part on the sites of exposure, 
the amount of virus present, the severity 
of the wounds, and whether sufficient 
contaminated tissue has been excised. If an 
exposed animal is to be custom- or home-
slaughtered for consumption, the slaughter 
should occur immediately after the exposure, 
and all tissues should be cooked thoroughly. 
Persons handling animals, carcasses, and 
tissues that have been exposed should use 
barrier precautions (49,50). Historically, 
federal guidelines for meat inspectors 
required that any animal known to have 
been exposed to rabies within 8 months be 
rejected for slaughter (51). The USDA Food 
and Inspection Service (FSIS) and state 
meat inspectors should be notified when 
such exposures occur in food animals before 
slaughter. 
 Rabies virus is widely distributed in tissues of 
rabid animals (52–54). Tissues and products 
from a rabid animal should not be used for 
human or animal consumption (55,56) or 
transplantation (57). Pasteurization and 
cooking inactivate rabies virus (58); therefore, 
inadvertently drinking pasteurized milk or 
eating thoroughly cooked animal products 
does not constitute a rabies exposure.
c) Other Animals. Other mammals exposed to a 
rabid animal should be euthanized immediately. 
Animals maintained in USDA-licensed research 
facilities or accredited zoological parks should be 
evaluated on a case-by-case basis in consultation 
with public health authorities. Options might 
include isolation, observation, or administration 
of rabies biologics (i.e., immune globulin or 
vaccine or both).
6. Management of Animals that Bite Humans
a) Dogs, Cats, and Ferrets. Rabies virus is excreted 
in the saliva of infected dogs, cats, and ferrets 
during illness and/or for only a few days before 
illness or death (59–61). Regardless of rabies 
vaccination status, a healthy dog, cat, or ferret that 
potentially exposes a person through a bite should 
be confined and observed daily for 10 days from 
the time of the exposure (62); administration of 
rabies vaccine to the animal is not recommended 
during the observation period to prevent 
confusion between signs of rabies and rare adverse 
reactions (13). Any illness in the animal should 
be reported immediately to the local health 
department. Animals should be evaluated by 
a veterinarian at the first sign of illness during 
confinement. If signs suggestive of rabies develop, 
the animal should be euthanized and the head 
submitted for testing as described in Part I.A.9. 
Any stray or unwanted dog, cat, or ferret that 
potentially exposes a person to rabies may be 
euthanized immediately and the head submitted 
for rabies examination.
b) Other Animals. Other animals that might have 
exposed a person to rabies should be reported 
immediately to the local health department. 
Management of animals other than dogs, cats, and 
ferrets depends on the species, the circumstances 
of the exposure, the epidemiology of rabies 
in the area, and the animals’ history, current 
health status, and the potential for exposure 
to rabies. The shedding period for rabies virus 
is undetermined for most species.  Previous 
vaccination of these animals might not preclude 
the necessity for euthanasia and testing. 
7. Outbreak Prevention and Control. The emergence 
of new rabies virus variants or the introduction of 
nonindigenous viruses poses a significant risk to 
humans, domestic animals, and wildlife (63–70). 
A rapid and comprehensive response includes the 
following measures (71):
a) Characterize Virus. Characterize the virus at the 
national reference laboratory.
b) Identify and Control Source. Identify and 
control the source of the virus introduction.
c) Enhance Surveillance. Enhance laboratory-based 
surveillance in wild and domestic animals.
d) Increase Vaccination. Increase animal rabies 
vaccination rates.
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e) Restrict Animals. Restrict the movement of 
animals.
f ) Evaluate Need to Reduce Vector Population. 
Evaluate the need for vector population reduction.
g) Coordinate Response. Coordinate a multiagency 
response.
h) Provide Outreach. Provide public and 
professional outreach and education.
8. Disaster Response. Animals might be displaced 
during and after man-made or natural disasters and 
need emergency sheltering (http://www.bt.cdc.gov/
disasters/petshelters.asp and http://www.avma.org/
disaster/default.asp) (72). Animal rabies vaccination 
and exposure histories often are not available for 
displaced animals. Disaster response creates situations 
in which animal caretakers might lack appropriate 
training and preexposure vaccination. In such 
situations, implementing and coordinating rabies 
prevention and control measures is critical to reduce 
the risk for rabies transmission and the need for 
human PEP. Such measures include the following:
a) Coordinate Relief. Coordinate relief efforts 
of individuals and organizations with the local 
emergency operations center before deployment.
b) Examine Animals. Examine each animal at a 
triage site for possible bite injuries or signs of 
rabies. 
c) Isolate Animals. Isolate animals exhibiting signs 
of rabies, pending evaluation by a veterinarian.
d) Check Animal Identifiers. Ensure that all 
animals have a unique identifier.
e) Vaccinate. Administer a rabies vaccination to 
all dogs, cats, and ferrets unless reliable proof of 
vaccination exists. 
f ) Adopt Caretaker Standards. Adopt minimum 
standards for animal caretakers as feasible, 
including personal protective equipment, 
preexposure rabies vaccination, and appropriate 
training in animal handling (73).
g) Maintain Documentation. Maintain 
documentation of animal disposition and location 
(e.g., returned to owner, died or euthanized, 
adopted, relocated to another shelter, and address 
of new location).
h) Provide Facilities for Animals that Have Been 
Exposed. Provide facilities to confine and observe 
animals involved in exposures (see Part I.B.6.).
i) Report Human Exposures. Report human 
exposures to rabies to appropriate public health 
authorities (see Part I.A.3.).
C. Prevention and Control Methods Related to Wildlife. 
The public should be warned not to handle or feed wild 
animals. Wild animals and hybrids that expose persons, 
pets, or livestock to rabies should be considered for 
euthanasia and rabies diagnosis. A person exposed by any 
wild animal should immediately report the incident to 
a health-care provider who, in consultation with public 
health authorities, can evaluate the need for PEP (9,10). 
 Translocation of infected wildlife has contributed to the 
spread of rabies (63–68,74); therefore, the translocation 
of known terrestrial rabies reservoir species should be 
prohibited. Whereas state-regulated wildlife rehabilitators 
and nuisance wildlife control operators might play a role 
in a comprehensive rabies control program, minimum 
standards for persons who handle wild animals should 
include rabies vaccination, appropriate training, and 
continuing education.
1. Carnivores. The use of oral rabies vaccines (ORV) for 
the mass vaccination of free-ranging wildlife should 
be considered in selected situations with the approval 
of the appropriate state agencies (14,75).  Success 
has been documented using ORV to control rabies 
in wildlife in North America (75–78). The currently 
licensed vaccinia-vectored ORV is labeled for use 
in raccoons and coyotes.  The distribution of ORV 
should be based on scientific assessments of the 
target species and followed by timely and appropriate 
analysis of surveillance data; such results should be 
provided to all stakeholders. In addition, parenteral 
vaccination (trap–vaccinate–release) of wildlife rabies 
reservoirs may be integrated into coordinated ORV 
programs to enhance their effectiveness. Continuous 
and persistent programs for trapping or poisoning 
wildlife do not reduce wildlife rabies reservoirs 
statewide. However, limited population control in 
high-contact areas (e.g., picnic grounds, camps, 
and suburban areas) might be indicated for the 
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removal of selected species of wildlife at high risk for 
having rabies. State agriculture, public health, and 
wildlife agencies should be consulted for planning, 
coordination, and evaluation of vaccination or 
population reduction programs (14).
2. Bats. From the 1950s through 2011, indigenous 
rabid bats have been reported from every state 
except Hawaii and have caused rabies in at least 43 
humans in the United States (79–92). Bats should be 
excluded appropriately from houses, public buildings, 
and adjacent structures to prevent direct association 
with humans (93,94). Such structures should then 
be made bat-proof by sealing entrances used by bats. 
Controlling rabies in bats through programs designed 
to reduce bat populations is neither feasible nor 
desirable.
Part II. Recommendations for 
Parenteral Rabies Vaccination 
Procedures
A. Vaccine Administration. All animal rabies vaccines 
should be restricted to use by or under the direct 
supervision of a veterinarian (95), except as 
recommended in Part I.B.1.
B. Vaccine Selection. Part III lists all vaccines licensed 
by USDA and marketed in the United States at the 
time of publication. New vaccine approvals or changes 
in label specifications made after publication of this 
report should be considered a part of this list. Any of 
the listed vaccines can be used for revaccination, even if 
the product is not the same as previously administered. 
Vaccines used in state and local rabies control programs 
should have at least a 3-year duration of immunity. 
This constitutes the most effective method of increasing 
the proportion of immunized dogs and cats in any 
population (96). No laboratory or epidemiologic data 
exist to support the annual or biennial administration of 
3- or 4-year vaccines following the initial series.
C. Adverse Events. No epidemiologic association exists 
between a particular licensed vaccine product and 
specific adverse events (13,97–99); although rare, adverse 
events including vomiting, swelling at the injection 
site, lethargy, hypersensitivity, and rabies in a previously 
vaccinated animal have been reported. Adverse events 
should be reported to the vaccine manufacturer and to 
USDA, Animal and Plant Health Inspection Service, 
Center for Veterinary Biologics (http://www.aphis.usda.
gov/animal_health/vet_biologics/vb_adverse_event.
shtml; telephone: 800-752-6255). No contraindication 
to rabies vaccination exists.  Animals with a previous 
history of anaphylaxis can be medically managed and 
observed after vaccination (46).
D. Wildlife and Hybrid Animal Vaccination. The safety 
and efficacy of parenteral rabies vaccination of wildlife 
and hybrids have not been established, and no rabies 
vaccines are licensed for these animals. Zoos or research 
institutions may establish vaccination programs to 
attempt to protect valuable animals; however, these 
programs should not replace appropriate public health 
activities that protect humans (see Part I.B.1.c.2).
E. Accidental Human Exposure to Vaccine. Human 
exposure to parenteral animal rabies vaccines listed 
in Part III does not constitute a risk for rabies virus 
infection. Human exposure to vaccinia-vectored ORVs 
should be reported to state health officials (100,101).
F. Rabies Certificate. All agencies and veterinarians 
should use NASPHV Form 51 (revised 2007), Rabies 
Vaccination Certificate, or an equivalent. This form 
can be obtained from vaccine manufacturers, NASPHV 
(available at http://www.nasphv.org/Documents/
RabiesVacCert.pdf ), or CDC (available at http://www.
cdc.gov/rabies/pdf/nasphv_form51.pdf ). The form must 
be completed in full and signed by the administering 
or supervising veterinarian. Computer-generated forms 
containing the same information also are acceptable.
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Part III: Rabies Vaccines Licensed and Marketed in the United States and 
Rabies Vaccine Manufacturer Contact Information
Adverse events after receipt of vaccine should be reported to the vaccine manufacturer (Tables 1 and 2) and to USDA, Animal 
and Plant Health Inspection Service, Center for Veterinary Biologics (http://www.aphis.usda.gov/animal_health/vet_biologics/
vb_adverse_event.shtml; telephone: 800-752-6255).
TABLE 1. Rabies vaccines licensed and marketed in the United States, 2011
Product name Produced by Marketed by For use in Dose





Rabvac 1 Boehringer Ingelheim   
   Vetmedica, Inc.† 
License no. 112
Boehringer Ingelheim  









IM or SC 
IM or SC
Rabvac 3 Boehringer Ingelheim  
   Vetmedica, Inc. 
License no. 112
Boehringer Ingelheim  










1 yr later and triennially 
1 yr later and triennially 
Annually
IM or SC 
IM or SC 
IM
Rabvac 3 TF Boehringer Ingelheim  
   Vetmedica, Inc. 
License no. 112
Boehringer Ingelheim  










1 yr later and triennially 
1 yr later and triennially 
Annually
IM or SC 
IM or SC 
IM
Continuum Rabies Intervet, Inc. 
License no. 165A






1 yr later and triennially 
1 yr later and 
   quadrennially
SC 
SC
EquiRab Intervet, Inc. 
License no. 165A
Intervet, Inc. Horses 1 mL 4 mos Annually IM
Prorab 1 Intervet, Inc. 
License no. 165A












IM or SC 
IM or SC 
IM
Defensor 1 Pfizer, Inc. 
License no. 189








IM or SC 
SC
Defensor 3 Pfizer, Inc. 
License no. 189












1 yr later and triennially 
1 yr later and triennially 
Annually 
Annually




Rabdomun Pfizer, Inc. 
License no. 189
Schering-Plough Animal  













1 yr later and triennially 
1 yr later and triennially 
Annually 
Annually




Rabdomun 1 Pfizer, Inc. 
License no. 189
Schering-Plough Animal  









IM or SC 
SC
Imrab 1 Merial, Inc. 
License no. 298










Imrab 1 TF Merial, Inc. 
License no. 298










Imrab 3 Merial, Inc. 
License no. 298


















1 yr later and triennially 
1 yr later and triennially 




IM or SC 
IM or SC 
IM or SC 
IM or SC 
IM or SC 
SC
See table footnotes on page 11.
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TABLE 1. (Continued) Rabies vaccines licensed and marketed in the United States, 2011
Product name Produced by Marketed by For use in Dose




Imrab 3 TF Merial, Inc. 
License no. 298









1 yr later and triennially 
1 yr later and triennially 
Annually
IM or SC 
IM or SC 
SC
Imrab Large Animal Merial, Inc. 
License no. 298











1 yr later and triennially
IM or SC 
IM or SC 
IM or SC





Merial, Inc. Cats 1mL 3 mos Annually SC
Combination (inactivated rabies)
Continuum DAP-R Intervet, Inc. 
License no. 165A





Intervet, Inc. Cats 1 mL 3 mos 1 yr later and triennially SC




Merial, Inc. Horses 1 mL 3 mos Annually IM





Merial, Inc. Cats 1 mL 8 wks 
 
3 mos
Every 3 wks until 3 mos  
   and annually 






Merial, Inc. Cats 1 mL 8 wks 
 
3 mos
Every 3 wks until 3 mos  
   and annually 
3 wks later and annually
SC
Oral (rabies glycoprotein, live vaccinia vector): restricted to use in state and federal rabies control programs
Raboral V-RG Merial, Inc. 
License no. 298
Merial, Inc. Coyotes 
Raccoons
N/A N/A As determined by local 
   authorities
Oral
Abbreviations: IM = intramuscular; N/A = not applicable; SC = subcutaneous; TF = thimerosal free.
* Minimum age (or older) and revaccinated 1 year later.
† Fort Dodge Animal Health was recently acquired by Boehringer Ingelheim Vetmedica, Inc.
§ One month = 28 days.
TABLE 2. Rabies vaccine manufacturer contact information
Manufacturer Phone number Internet address
Boehringer Ingelheim Vetmedica, Inc. 800-638-2226 Not available
Intervet, Inc. 800-441-8272 http://www.intervetusa.com
Merial, Inc. 888-637-4251 http://us.merial.com
Pfizer, Inc.  800-366-5288 http://www.pfizerah.com
Recommendations and Reports
12 MMWR / November 4, 2011 / Vol. 60 / No. 6
References
 1. American Public Health Association. Rabies. In: Heymann D, ed. 
Control of communicable diseases manual. 19th ed. Washington, DC: 
American Public Health Association; 2008:498–508.
 2. Blanton JD, Palmer D, Christian KA, Rupprecht CE. Rabies 
surveillance in the United States during 2009.  J Am Vet Med Assoc 
2010;237:646–57. 
 3. Castrodale L, Walker V, Baldwin J, Hofmann J, Hanlon C. Rabies in 
a puppy imported from India to the USA, March 2007.  Zoonoses 
Public Health 2008;55:427–30.
 4. CDC. Rabies in a dog imported from Iraq—New Jersey, June 2008. 
MMWR 2008;57:1076–8. 
 5. McQuiston JH, Wilson T, Harris S, et al. Importation of dogs into the 
United States: risks from rabies and other zoonotic diseases. Zoonoses 
Public Health 2008;55:421–6.
 6. Velasco-Villa A, Reeder SA, Orciari LA, et al. Enzootic rabies 
elimination from dogs and reemergence in wild terrestrial carnivores, 
United States. Emerg Infect Dis 2008;14:1849–54. 
 7. Beran GW. Rabies and infections by rabies-related viruses. In: Beran 
GW, ed. Handbook of zoonoses section B: Viral, 2nd ed. Boca Raton, 
FL: CRC Press; 1994:307–57.
 8. Council of State and Territorial Epidemiologists. Public health reporting 
and national notification for animal rabies. Infectious disease positions 
statements, June 2009. Atlanta, GA:  Council of State and Territorial 
Epidemiologists. Available at http://www.cste.org/ps2009/09-ID-12.
pdf. Accessed September 1, 2011.
 9. CDC. Human rabies prevention—United States,  2008. 
Recommendations of the Advisory Committee on Immunization 
Practices (ACIP). MMWR 2008;57(No. RR-3).
 10. CDC. Use of  reduced (4-dose) vaccine schedule for postexposure 
prophylaxis to prevent human rabies. Recommendations of the 
Advisory Committee on Immunization Practices (ACIP). MMWR 
2010;59(No. RR-2).
 11. McQuiston J, Yager PA, Smith JS, Rupprecht CE. Epidemiologic 
characteristics of rabies virus variants in dogs and cats in the United 
States, 1999. J Am Vet Med Assoc 2001;218:1939–42.
 12. Murray KO, Holmes KC, Hanlon CA. Rabies in vaccinated dogs and 
cats in the United States, 1997–2001. J Am Vet Med Assoc 
2009;235:691–5.
 13. Frana TS, Clough NE, Gatewood DM, Rupprecht CE. Postmarketing 
surveillance of rabies vaccines for dogs to evaluate safety and efficacy. 
J Am Vet Med Assoc 2008;232:1000–2.
 14. Hanlon CA, Childs JE, Nettles VF, et al. Recommendations of the 
Working Group on Rabies. Article III: rabies in wildlife. J Am Vet Med 
Assoc 1999;215:1612–8.
 15. Slate D, Algeo TD, Nelson KM, et al. Oral rabies vaccination in North 
America: opportunities, complexities, and challenges. PLoS Negl Trop 
Dis 2009;3:1–9
 16. Council of State and Territorial Epidemiologists. Electronic laboratory 
reporting in the US: underfunded and under potential, or, 
recommendations for the implementation of ELR in the US. Policy 
Positions Statements. Atlanta, GA: Council of State and Territorial 
Epidemiologists; 2009. Available at http://www.cste.org/
ps2009/09-SI-03.pdf. Accessed September 1, 2011.
 17. Council of State and Territorial Epidemiologists. Process statement for 
immediately nationally notifiable conditions. Policy Positions 
Statements, Atlanta, GA: Council of State and Territorial 
Epidemiologists; 2009. Available at http://www.cste.org/
ps2009/09-SI-04.pdf. Accessed September 1, 2011.
 18. Hanlon CA, Smith JS, Anderson GR, et al. Recommendations of the 
Working Group on Rabies. Article II: laboratory diagnosis of rabies. J 
Am Vet Med Assoc 1999;215:1444–6.
 19. Rudd RJ, Smith JS, Yager PA, et al. A need for standardized rabies-virus 
diagnostic procedures: effect of cover-glass mountant on the reliability 
of antigen detection by the fluorescent antibody test. Virus Res 
2005;111:83–8.
 20. American Veterinary Medical Association. AVMA guidelines on 
euthanasia. Schaumburg, IL: American Veterinary Medical Association; 
2007. Available at http://www.avma.org/issues/animal_welfare/
euthanasia.pdf. Accessed September 1, 2011.
 21. Michigan Rabies Working Group. Humane euthanasia of bats for 
public health rabies testing. Lansing, MI: Michigan Rabies Working 
Group; 2008. Available at http://www.michigan.gov/documents/
emergingdiseases/Humane_Euthanasia_of_Bats-Final_244979_7.pdf. 
Accessed September 1, 2011.
 22. CDC. Public health response to a potentially rabid bear cub—Iowa, 
1999. MMWR 1999;48:971–3. 
 23. Niezgoda M, Rupprecht CE. Standard operating procedure for the 
direct rapid immunohistochemistry test for the detection of rabies virus 
antigen. National Laboratory Training Network Course. Atlanta, GA: 
US Department of Health and Human Services, CDC; 2006:1–16. 
Available at http://www.rabiesblueprint.com/IMG/pdf/DRIT_SOP.
pdf. Accessed September 1, 2011.
 24. Lembo T, Niezgoda M, Velasco-Villa A, Cleaveland S, Ernest E, 
Rupprecht CE. Evaluation of a direct, rapid immunohistochemical test 
for rabies diagnosis. Emerg Infect Dis 2006;12:310–3.
 25. Dürr S, Naïssengar S, Mindekem R, et al. Rabies diagnosis for 
developing countries. PLoS Negl Trop Dis 2008;26:e206.
 26. Saturday GA, King R, Fuhrmann L. Validation and operational 
application of a rapid method for rabies antigen detection. US Army 
Med Dep J 2009;Jan–Mar:42–5.
 27. Tizard I, Ni Y. Use of serologic testing to assess immune status of 
companion animals. J Am Vet Med Assoc 1998;213:54–60.
 28. Greene CE, ed. Rabies and other lyssavirus infections. In: Infectious 
diseases of the dog and cat. 3rd ed. London, England: Saunders Elsevier; 
2006:167–83.
 29. Rupprecht CE, Gilbert J, Pitts R, Marshall K, Koprowski H. Evaluation 
of an inactivated rabies virus vaccine in domestic ferrets. J Am Vet Med 
Assoc 1990;196:1614–6.
 30. Moore SM, Hanlon CA. Rabies-specific antibodies: measuring 
surrogates of protection against a fatal disease. PLoS Negl Trop Dis 
2010;4:e595.
 31. Aubert MF. Practical significance of rabies antibodies in cats and dogs. 
Rev Sci Tech 1992;11:735–60.
 32. Muirhead TL, McClure JT, Wichtel JJ, et al. The effect of age on serum 
antibody titers after rabies and influenza vaccination in healthy horses. 
J Vet Intern Med 2008;22:654–61.
 33. Shimazaki Y, Inoue S, Takahashi C, et al. Immune response to Japanese 
rabies vaccine in domestic dogs. J Vet Med B 2003;50:95–8.
 34. Cliquet F, Verdier Y, Sagné L, et al. Neutralising antibody titration in 
25,000 sera of dogs and cats vaccinated against rabies in France, in the 
framework of the new regulations that offer an alternative to quarantine. 
Rev Sci Tech 2003;22:857–66.
Recommendations and Reports
MMWR / November 4, 2011 / Vol. 60 / No. 6 13
 35. Rabies. In: Guidelines for the vaccination of horses. Lexington, KY: 
American Association of Equine Practitioners; 2009. Available at http://
www.aaep.org/rabies.htm. Accessed September 1, 2011.
 36. CDC. Compendium of measures to prevent disease and injury associated 
with animals in public settings, 2007. MMWR 2007;56(No. RR-5).
 37. Bender J, Schulman S. Reports of zoonotic disease outbreaks associated 
with animal exhibits and availability of recommendations for preventing 
zoonotic disease transmission from animals to people in such settings. 
J Am Vet Med Assoc 2004;224:1105–9.
 38. American Veterinary Medical Association. Private ownership of wild 
animals. Schaumburg, IL: American Veterinary Medical Association; 
2006. Available at http://www.avma.org/issues/policy/wild_animal_
ownership.asp. Accessed September 1, 2011.
 39. American Veterinary Medical Association. Position on canine hybrids. 
Schaumburg, IL: American Veterinary Medical Association; 2008.
 40. Siino BS. Crossing the line: the case against hybrids. New York City, 
NY: American Society for the Prevention of Cruelty to Animals, Animal 
Watch; 2000:22–9. Available at http://www.petfinder.com/before-pet-
adoption/case-against-hybrids.html?page-index=1&query=hybrids. 
Accessed September 1, 2011.
 41. Jay MT, Reilly KF, DeBess EE, Haynes EH, Bader DR, Barrett LR. 
Rabies in a vaccinated wolf-dog hybrid. J Am Vet Med Assoc 
1994;205:1729–32.
 42. CDC. An imported case of rabies in an immunized dog. MMWR 
1987;36:94–6.
 43. CDC. Imported dog and cat rabies—New Hampshire, California. 
MMWR 1988;37:559–60.  
 44. Hanlon CA, Niezgoda MN, Rupprecht CE. Postexposure prophylaxis 
for prevention of rabies in dogs. Am J Vet Res 2002;63:1096–100.
 45. Rabies vaccine, killed virus. 9 C.F.R. Sect. 113.209 (2003). 
 46. Greene CE, ed. Immunoprophylaxis. In: Infectious diseases of the dog 
and cat.  3rd ed. London, England: Saunders,  Elsevier; 
2006;1069–119.
 47. Willoughby, RE. “Early death” and the contraindication of vaccine 
during rabies treatment. Vaccine 2009;27:7173–7.
 48. Mansfield K, McElhinney L, Hübschle O, et al. A molecular 
epidemiological study of rabies epizootics in kudu (Tragelaphus 
strepsiceros) in Namibia. BMC Vet Res 2006;2:2.
 49. Viral agents. In: US Department of Health and Human Services. 
Biosafety in microbiological and biomedical laboratories. 5th ed. 
Washington, DC: U.S. Government Printing Office; 2007:234–5. 
Available at http://www.cdc.gov/biosafety/publications/bmbl5/
BMBL5_sect_VIII_e.pdf. Accessed September 1, 2011.
 50. Wertheim HFL, Nguyen TQ, Nguyen KAT, et al. Furious rabies after 
an atypical exposure. PLoS Med 2009;6(3):0264–8.
 51. Ante-mortem inspection. In: US Meat and Poultry Inspection Program. 
Meat and poultry inspection manual. Washington, DC: US 
Government Printing Office; 1973:314.
 52. Debbie JG, Trimarchi CV. Pantropism of rabies virus in free-ranging 
rabid red fox (Vulpes fulva). J Wildl Dis 1970;6:500–6.
 53. Fekadu M, Shaddock JH. Peripheral distribution of virus in dogs 
inoculated with two strains of rabies virus. Am J Vet Res 
1984;45:724–729.
 54. Charlton, KM. The pathogenesis of rabies and other lyssaviral 
infections: recent studies. Curr Top Microbiol Immunol 
1994;187:95–119.
 55. Afshar A. A review of non-bite transmission of rabies virus infection. 
Br Vet J 1979;135:142–8.
 56. CDC. Mass treatment of humans who drank unpasteurized milk from 
rabid cows—Massachusetts, 1996–1998. MMWR 1999;48:228–9. 
 57. CDC. U.S. public health service guideline on infectious disease issues 
in xenotransplantation. MMWR 2001;50(No. RR–15).
 58. Turner GS, Kaplan C. Some properties of fixed rabies virus. J Gen 
Virol 1967;1:537–51.
 59. Vaughn JB, Gerhardt P, Paterson J. Excretion of street rabies virus in 
saliva of cats. J Am Med Assoc 1963;184:705.
 60. Vaughn JB, Gerhardt P, Newell KW. Excretion of street rabies virus in 
saliva of dogs. J Am Med Assoc 1965;193:363–8.
 61. Niezgoda M, Briggs DJ, Shaddock J, Rupprecht CE. Viral excretion 
in domestic ferrets (Mustela putorius furo) inoculated with a raccoon 
rabies isolate. Am J Vet Res 1998;59:1629–32.
 62. Tepsumethanon V, Lumlertdacha B, Mitmoonpitak C, Sitprija V, 
Meslin FX, Wilde H. Survival of naturally infected rabid dogs and cats. 
Clin Infect Dis 2004;39:278–80.
 63. Jenkins SR, Perry BD, Winkler WG. Ecology and epidemiology of 
raccoon rabies. Rev Infect Dis 1988;10(Suppl 4):S620–5.
 64. CDC. Translocation of coyote rabies—Florida, 1994. MMWR 
1995;44:580–7. 
 65. Rupprecht CE, Smith JS, Fekadu M, Childs JE. The ascension of 
wildlife rabies: a cause for public health concern or intervention? Emerg 
Infect Dis 1995;1:107–14. 
 66. Constantine DG. Geographic translocation of bats: known and 
potential problems. Emerg Infect Dis 2003;9:17–21. 
 67. Krebs JW, Strine TW, Smith JS, Rupprecht CE, Childs JE. Rabies 
surveillance in the United States during 1993. J Am Vet Med Assoc 
1994;1695–709.
 68. VF Nettles, JH Shaddock, RK Sikes, CR Reyes. Rabies in translocated 
raccoons. Am J Public Health 1979;69:601–2.
 69. RM Engeman, KL Christensen, MJ Pipas, DL Bergman. Population 
monitoring in support of a rabies vaccination program for skunks in 
Arizona. J Wildl Dis 2003;39:746–50.
 70. Leslie MJ, Messenger S, Rohde RE, et al. Bat-associated rabies virus in 
skunks. Emerg Infect Dis 2006;12:1274–7. 
 71. Rupprecht CE, Hanlon CA, Slate D. Control and prevention of rabies 
in animals: paradigm shifts. Dev Biol (Basel). 2006;125:103–11.
 72. Pets Evacuation and Transportations Standards Act of 2006. P.L. 109-
308, 109th Cong., 120 Stat. 1725 (2006). 
 73. National Animal Control Association. National Animal Control 
Association guidelines. Kansas City, MO: National Animal Control 
Association. Available at http://www.nacanet.org/guidelines.html. 
Accessed September 1, 2011.
 74. Chipman R, Slate D, Rupprecht C, Mendoza M. Downside risk of 
translocation. In: Dodet B, Fooks AR, Muller T, Tordo N; Scientific 
& Technical Department of the OIE, eds: Towards the elimination of 
rabies in Eurasia. Dev Biol 2008;131:223–32.
 75. Slate D, Rupprecht CE, Rooney JA, Donovan D, Lein DH, Chipman 
RB. Status of oral rabies vaccination in wild carnivores in the United 
States. Virus Res 2005;111:68–76.
 76. Sidwa TJ, Wilson PJ, Moore GM, et al. Evaluation of oral rabies 
vaccination programs for control of rabies epizootics in coyotes and 
gray foxes: 1995–2003. J Am Vet Med Assoc 2005;227:785–92.
 77. MacInnes CD, Smith SM, Tinline RR, et al.  Elimination of rabies 
from red foxes in eastern Ontario.  J Wildl Dis 2001;37:119–32.
 78. Rosatte RC, Power MJ, Donovan D, et al. Elimination of arctic variant 
of rabies in red foxes, metropolitan Toronto. Emerg Infect Dis 
2007;1325–27. 
Recommendations and Reports
14 MMWR / November 4, 2011 / Vol. 60 / No. 6
 79. Messenger SL, Smith JS, Rupprecht CE. Emerging epidemiology of 
bat-associated cryptic cases of rabies in humans in the United States. 
Clin Infect Dis 2002;35:738–47.
 80. CDC. Human rabies—California, 2002. MMWR 2002;51:686–8. 
 81. CDC. Human rabies—Tennessee, 2002. MMWR 2002;51:828–9. 
 82. CDC. Human rabies—Iowa, 2002. MMWR 2003;52:47–8. 
 83. CDC. Human death associated with bat rabies—California, 2003. 
MMWR 2004;53:33–5. 
 84. CDC. Recovery of a patient from clinical rabies, Wisconsin, 2004. 
MMWR 2004;53:1171–3. 
 85. CDC. Human rabies—Mississippi, 2005. MMWR 2006;55:207–8. 
 86. CDC. Human rabies—Indiana and California, 2006. MMWR 
2007;56:361–5. 
 87. CDC. Human rabies—Minnesota, 2007. MMWR 2008;57:460–2. 
 88. CDC. Human rabies—Missouri, 2008. MMWR 2009;58:1207–9. 
 89. CDC. Human rabies—Kentucky/Indiana, 2009. MMWR 
2010;59:393–6. 
 90. CDC. Human rabies—Virginia, 2009. MMWR 2010;591236–8. 
 91. CDC. Presumptive abortive human rabies—Texas, 2009. MMWR 
2010;59:185–90. 
 92. CDC. Human rabies—Michigan, 2009. MMWR 2011;60:437–40. 
 93. Greenhall AM. House bat management. US Fish and Wildlife Service, 
Resource Publication 143;1982. Jamestown, ND: Northern Prairie 
Wildlife Research Center Online; 1982. Available at http://www.npwrc.
usgs.gov/resource/mammals/housebat/index.htm. Accessed September 
1, 2011.
 94. Greenhall AM, Frantz SC. Bats. In: Hygnstrom SE, Timm RM, Larson 
GE, eds. Prevention and control of wildlife damage. Cooperative 
Extension Division Institute of Agriculture and Natural Resources 
University of Nebraska—Lincoln; United States Department of 
Agriculture Animal and Plant Health Inspection Service Animal 
Damage Control; Great Plains Agricultural Council Wildlife 
Committee; 1994. Available at http://icwdm.org/handbook/mammals/
bats.asp. Accessed September 1, 2011.
 95. American Veterinary Medical Association. Model rabies control 
ordinance. Schaumburg, IL: American Veterinary Medical Association; 
2008. Available at http://www.avma.org/issues/policy/AVMA-Model-
Rabies-Ordinance.pdf. Accessed September 1, 2011.
 96. Bunn TO. Canine and feline vaccines, past and present. In Baer GM, 
ed. The natural history of rabies. 2nd ed. Boca Raton, FL: CRC Press; 
1991:415–25.
 97. Macy DW, Hendrick MJ. The potential role of inflammation in the 
development of postvaccinal sarcomas in cats. Vet Clin North Am 
Small Anim Pract 1996;26:103–9.
 98. Gobar GM, Kass PH. World wide web-based survey of vaccination 
practices, postvaccinal reactions, and vaccine site-associated sarcomas 
in cats. J Am Vet Med Assoc 2002;220:1477–82.
 99. Kass PH, Spangler WL, Hendrick MJ, et al. Multicenter case-control 
study of risk factors associated with development of vaccine-associated 
sarcomas in cats. J Am Vet Med Assoc 2003;223:1283–92.
 100. Rupprecht CE, Blass L, Smith K, et al. Human infection due to 
recombinant vaccinia-rabies glycoprotein virus. N Engl J Med 
2001;345:582–6.
 101. CDC. Human vaccinia infection after contact with a raccoon rabies 
vaccine bait—Pennsylvania, 2009. MMWR 2009;58:1204–7. 
Recommendations and Reports
MMWR / November 4, 2011 / Vol. 60 / No. 6 15
National Association of State Public Health Veterinarians
Committee Members
Catherine M. Brown, DVM, Chair, Massachusetts Department of Public Health, Jamaica Plain, Massachusetts; Lisa Conti, DVM, Florida Department of 
Health, Tallahassee, Florida; Paul Ettestad, DVM, New Mexico Department of Health, Sante Fe, New Mexico; Mira J. Leslie, DVM, Ministry of Agriculture 
and Lands, Abbotsford, British Columbia; Faye E. Sorhage, VMD, New Jersey Department of Health and Senior Services, Trenton, New Jersey; Ben Sun, 
DVM, Nevada Department of Health and Human Services, Carson City, Nevada.
Committee Consultants 
Donald Hoenig, VMD, American Veterinary Medical Association, Augusta, Maine; Donna M. Gatewood, DVM, U.S. Department of Agriculture, Center 
for Veterinary Biologics, Ames, Iowa; Lorraine Moule, National Animal Control Association, Windsor, Connecticut; Barbara Nay, Animal Health Institute, 
Millsboro, Delaware; Raoult Ratard, MD, Council of State and Territorial Epidemiologists, Metarie, Louisiana; Charles E. Rupprecht, VMD, PhD, CDC, 
Atlanta, Georgia; Dennis Slate, PhD, U.S. Department of Agriculture Wildlife Services, Concord, New Hampshire; James Powell, MS, Association of Public 
Health Laboratories, Madison, Wisconsin; Burton Wilcke, Jr., PhD, American Public Health Association, Burlington, Vermont.
Recommendations and Reports
16 MMWR / November 4, 2011 / Vol. 60 / No. 6
Recommendations and Reports
MMWR / November 4, 2011 / Vol. 60 / No. 6 17
U.S. Government Printing Office: 2012-523-043   Region IV ISSN: 1057-5987
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC) and is available free of 
charge in electronic format. To receive an electronic copy each week, visit MMWR’s free subscription page at http://www.cdc.gov/mmwr/mmwrsubscribe.
html. Paper copy subscriptions are available through the Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402; 
telephone 202-512-1800.
Address all inquiries about the MMWR Series, including material to be considered for publication, to Editor, MMWR Series, Mailstop E-90, CDC, 1600 
Clifton Rd., N.E., Atlanta, GA 30333 or to mmwrq@cdc.gov. 
All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations 
or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of these sites. URL addresses 
listed in MMWR were current as of the date of publication.
Recommendations and Reports
